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Appraisal Critically Appraised Papers
Summary of: Bisset L, Beller E, Jull G, Brooks P, Darnell 
R, Vicenzino B (2006) Mobilisation with movement and 
exercise, corticosteroid injection, or wait and see for tennis 
elbow: randomised trial. BMJ 333: 939–945. [Prepared by 
Gro Jamtvedt and Kåre Birger Hagen, CAP Editors.]
Question: What is the effect of physiotherapy compared 
with a wait and see approach or corticosteroid injections 
for tennis elbow? Design: Randomised controlled trial with 
concealed allocation, assessor blinding, and intention-to-
treat analysis. Setting: Community setting in Australia. 
Participants: 198 respondents to advertisements of the 
trial, aged 18 to 65 years, with a clinical diagnosis of tennis 
elbow of a minimum six weeks’ duration, who had not 
received any treatment of the elbow by a health practitioner 
in the previous six months. Interventions: On entering the 
study all participants were given an information booklet 
outlining the disease process and providing practical advice 
on self management and ergonomics. Participants were 
randomised to physiotherapy, corticosteroid injections, 
or wait and see. The physiotherapy group received eight 
treatments of 30 minutes over six weeks, consisting of 
elbow manipulation (mobilisation with movement) and 
therapeutic exercise. They were also taught home exercises 
with a resistant exercise band and self manipulation. The 
corticosteroid injection group received an injection of 10 
mg of triaminolone acetonide in 1 mL of lidocaine, plus a 
repeat injection after two weeks if necessary. The wait and 
see group received reassurance that the condition would 
Physiotherapy interventions improve tennis elbow with 
superior long-term outcomes to corticosteroid injections
Synopsis
settle and advice to remain active without aggravating their 
pain. Outcomes: Global improvement (those who rated 
themselves as ‘completely recovered’ or ‘much improved’ 
were considered to be successes), grip force, and an 
assessor’s rating of severity measured at six and 52 weeks. 
Results: At six weeks follow-up 78% of the participants 
reported success with injections compared with 65% for 
physiotherapy [relative risk reduction (RRR) 0.4 (99% CI 
−0.2 to 0.9)] and 27% for wait and see [RRR 0.7 (99% CI 
0.4 to 0.9)]. At 52 weeks, the injection group participants 
were significantly worse on all primary outcomes compared 
with the physiotherapy group [RRR for success 0.3 (99% 
CI 0.1 to 0.5); number needed to treat = 4] and on two out 
of the three measures compared with wait and see [RRR for 
success 0.3 (99% CI 0.04 to 0.4)]. Physiotherapy performed 
significantly better than wait and see at six weeks for all 
outcome measures; however, by 52 weeks no difference 
existed on any primary outcome measure, as most 
participants were successes. Recurrences after injection 
were significantly greater than in the physiotherapy [RRR 
0.9 (99% CI 0.6 to 1.1)] or wait and see [RRR 0.9 (99% CI 
0.6 to 1.1)] groups, which were not significantly different 
from each other [RRR 0.2 (99% CI –1.4 to 1.7)]. Patients 
who received physiotherapy also sought significantly 
less other treatment. Conclusion: Recurrence rates were 
higher and recovery delayed in the mid to long term after 
corticosteroid injection compared with physiotherapy or 
wait and see. Physiotherapy was superior to injection after 
52 weeks and to wait and see at six weeks.
Commentary
This study matches the design and closely resembles another 
study of three different interventions for tennis elbow 
(Smidt 2002), appraised in a CAP in 2002 (Vasseljen 2002). 
It is strong evidence when two high quality studies in two 
of the highest ranked medical journals show very similar 
results. Both studies provide evidence that corticosteroid 
injection (CI), while favourable in the short term, has high 
recurrence rates and causes delayed recovery in the mid to 
long term, with outcomes inferior to both wait and see (WS) 
and physiotherapy (PT).
Although PT is favoured over WS in both studies, only 
Bisset et al are able to show significant effects, primarily 
in the short term (six weeks). This translates into a number 
needed to treat of three, meaning at 6 weeks every third 
patient will benefit from receiving PT as opposed to WS.
The PT interventions differed somewhat in the two studies, 
with emphasis on deep friction massage, ultrasound, and 
exercises in the study by Smidt, and on elbow mobilisation 
with movement and exercises in the current study. 
Interestingly, there was much less need for additional 
treatment in the PT group in this study compared to the 
Smidt study (21% vs 81%). There might thus be some 
support for the PT approach advocated by Bisset, however 
the most favourable PT treatment or treatment combination 
remains to be revealed. Future studies should include cost 
effectiveness comparisons.
When WS shows consistent and significantly better results 
than CI in the mid to long term the use of these injections for 
tennis elbow should be questioned. An issue does, however, 
remain: why do corticosteroid injections seem to work 
well up until 6 weeks? Studies of tennis elbow have shown 
signs of halted repair and degenerative processes consistent 
with tendinosis and lack of evidence of inflammation 
(Kraushaar 1999). Recent evidence indicates that the 
pathology of tennis elbow involves neovascularisation 
(formation of small probably non-functional blood vessels 
and accompanying nerves within and around the painful 
tendon). This is supported by the favourable response to 
sclerosing injections, which collapse the vessels and its 
nerves (Zeisig et al 2006). It can only be speculated whether 
CI have somewhat similar effects, but which are reversed 
after a few weeks. For now, there is sound evidence for 
physiotherapists to continue to treat tennis elbow within the 
scope suggested by these studies.
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